Announcements
- Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time
- Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer’s Disease
- Lantheus Welcomes CMS’ Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient Access
- Lantheus Appoints Jamie Spaeth as Chief People Officer
- Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers
- Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform
- Lantheus to Present at the William Blair 44th Annual Growth Stock Conference
- Lantheus Announces Executive Appointments to Accelerate Innovation
- Lantheus Reports First Quarter 2024 Financial Results
- Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time
More ▼
Key statistics
As of last trade Lantheus Holdings Inc (0L8:MUN) traded at 107.35, -4.92% below its 52-week high of 112.90, set on Jul 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 107.35 |
---|---|
High | 107.35 |
Low | 107.35 |
Bid | 107.90 |
Offer | 108.90 |
Previous close | 107.35 |
Average volume | 200.00 |
---|---|
Shares outstanding | 69.31m |
Free float | 67.53m |
P/E (TTM) | 18.56 |
Market cap | 8.43bn USD |
EPS (TTM) | 6.55 USD |
Data delayed at least 15 minutes, as of Jul 22 2024 07:02 BST.
More ▼